IFNG and neoplasm: After tumor immunotherapy, IFNγ released by activated CD8 + T cells downregulates the expression of SLC7A11 and SLC3A2, thereby inhibiting the uptake of cystine in tumor cells and enhancing LPO and ferroptosis.